FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Akorn Erythromycin Ophthalmic Ointment 0 Recall

ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0

Akorn, Inc. · Gurnee, IL

Risk level
Class II
Reported by FDA
Jan 25, 2023
Recall ID
D-0138-2023
Check your lot numberHow we source this data

Summary

Akorn recalled Erythromycin Ophthalmic Ointment 0 starting Oct 13, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0138-2023 on Jan 25, 2023. Reason: CGMP Deviations:. Status: Ongoing.

Why it was recalled

CGMP Deviations:

Product description

ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5%, Net Weight: 3.5g (1/8 oz) per tube, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-070-35

Lot numbers, UPCs & expiration codes

Lot: 0L58A, EXP 10/31/2022; 1B21A, 1B31A, EXP 1/31/2023; 1C44A, 1C58A, 1C58B, EXP 2/28/2023; 1E13A, 1E24A, EXP 4/30/2023; 1C57A, EXP 2/28/2023; 1G60A, 1G62A, 1G63A, EXP 6/30/2023; 1J34B, 1J40A, 1J21A, EXP 8/31/2023; 1K74A, EXP 9/30/2023; 1L93A, 1L96B, 1L96A, EXP 10/31/2023; 1M25A, 1M24A, 1M31A, EXP 11/30/2023; 2A02A, 2A10A, EXP 12/31/2023; 2C07A, EXP 2/29/2024; 2D47A, EXP 3/31/2024; 2E50A, 2E51A, EXP 4/30/2024;

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0138-2023
Classification
Class II
Status
Ongoing
Recall initiated
Oct 13, 2022
FDA report date
Jan 25, 2023
Quantity
1,109,600 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-0138-2023, exactly as published.

Show all FDA fields
City
Gurnee
State
IL
Status
Ongoing
Country
United States
Event ID
90948
Address
5605 Centerpoint Ct Ste A
Code information
Lot: 0L58A, EXP 10/31/2022; 1B21A, 1B31A, EXP 1/31/2023; 1C44A, 1C58A, 1C58B, EXP 2/28/2023; 1E13A, 1E24A, EXP 4/30/2023; 1C57A, EXP 2/28/2023; 1G60A, 1G62A, 1G63A, EXP 6/30/2023; 1J34B, 1J40A, 1J21A, EXP 8/31/2023; 1K74A, EXP 9/30/2023; 1L93A, 1L96B, 1L96A, EXP 10/31/2023; 1M25A, 1M24A, 1M31A, EXP 11/30/2023; 2A02A, 2A10A, EXP 12/31/2023; 2C07A, EXP 2/29/2024; 2D47A, EXP 3/31/2024; 2E50A, 2E51A, EXP 4/30/2024;
Postal code
60031-5278
Report date
Jan 25, 2023
Product type
Drugs
Recall number
D-0138-2023
Classification
Class II
Recalling firm
Akorn, Inc.
Product quantity
1,109,600 tubes
Reason for recall
CGMP Deviations:
Voluntary / mandated
Voluntary: Firm initiated
Product description
ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5%, Net Weight: 3.5g (1/8 oz) per tube, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-070-35
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 13, 2022
Initial firm notification
Letter
Center classification date
Jan 13, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0138-2023, published Jan 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls